1. Home
  2. AKR vs SUPN Comparison

AKR vs SUPN Comparison

Compare AKR & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acadia Realty Trust

AKR

Acadia Realty Trust

HOLD

Current Price

$22.37

Market Cap

2.9B

Sector

Real Estate

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$47.05

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKR
SUPN
Founded
1993
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
1996
2010

Fundamental Metrics

Financial Performance
Metric
AKR
SUPN
Price
$22.37
$47.05
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$22.25
$61.60
AVG Volume (30 Days)
1.3M
737.5K
Earning Date
04-28-2026
05-05-2026
Dividend Yield
3.69%
N/A
EPS Growth
N/A
N/A
EPS
0.22
N/A
Revenue
$410,757,000.00
$392,755,000.00
Revenue This Year
$3.21
$22.70
Revenue Next Year
$12.17
$19.14
P/E Ratio
$101.77
N/A
Revenue Growth
14.20
N/A
52 Week Low
$18.14
$32.83
52 Week High
$22.90
$59.68

Technical Indicators

Market Signals
Indicator
AKR
SUPN
Relative Strength Index (RSI) 57.37 50.41
Support Level $20.87 $43.43
Resistance Level $22.90 $52.30
Average True Range (ATR) 0.38 1.62
MACD 0.07 -0.14
Stochastic Oscillator 74.56 24.38

Price Performance

Historical Comparison
AKR
SUPN

About AKR Acadia Realty Trust

Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company operates through three segments: REIT Portfolio segment consists of high-quality retail properties located in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon; Investment Management segment holds the retail real estate in which the company co-invests with high-quality institutional investors; and Structured Financing segment consists of earnings and expenses related to notes and mortgages receivable Fees earned by the company as the general partner or managing member through Investment Management.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: